Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963). [electronic resource]
Producer: 20111206Description: 586-600 p. digitalISSN:- 1525-6073
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biological Clocks -- physiology
- Circadian Rhythm -- physiology
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Humans
- Leucovorin -- administration & dosage
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Metastasis
- Neutropenia -- chemically induced
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Prognosis
- Survival Analysis
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.